ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.91−0.03 (-3.15%)
Close on Nov 18, 2026Market cap $24.27MP/E –Yield –
ABVC BioPharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
ABVC BioPharma's price to sales ratio was 49.7× on Apr 30, 2025, against 65.1× a year earlier. Over the last 4 years it ranged from 4.5× to 334.9×, with a median of 80.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 49.7× | +35.0 |
| 2024 | Dec 31, 2024 | 14.7× | +7.1 |
| 2023 | Dec 29, 2023 | 7.6× | −145.7 |
| 2022 | Jan 31, 2022 | 153.2× | −54.6 |
| 2021 | Dec 31, 2021 | 207.8× | +8.1 |
| 2020 | Dec 31, 2020 | 199.7× | – |
See a number that looks wrong?